Although he has admitted to minimizing the risks of opioid analgesics, Russell Portenoy, MD, is still sought out as a key opinion leader on these drugs — and his latest speaking engagement is at a 2-day National Institutes of Health workshop on opioids that begins Monday.

Click Here to read more